ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 120,80
-0,94%
Dow Jones
42 801,72
0,52%
DAX
23 008,94
-1,87%
Brent Oil
70,235
0,00%
Bitcoin
85 976,39
-0,21%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Maxcyte Inc (MXCT)

  7. Maxcyte Inc (MXCT) Actualités

MXCT

Maxcyte (MXCT)

Maxcyte Inc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:MXCT
DateHeureSourceTitreSymboleSociété
04/03/202516h38RNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
19/02/202516h23RNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/02/202510h30Alliance NewsAlliance NewsMaxCyte partners with TG Therapeutics on autoimmune cell therapyLSE:MXCTMaxcyte Inc
12/02/202508h00RNS Regulatory NewsMaxCyte, Inc. Strategic Platform License with TG TherapeuticsLSE:MXCTMaxcyte Inc
07/02/202508h00RNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
31/01/202516h18RNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
30/01/202514h55Alliance NewsAlliance NewsMaxCyte buys gene therapy analytics firm SeQure DxLSE:MXCTMaxcyte Inc
30/01/202508h00RNS Regulatory NewsMaxCyte, Inc. MaxCyte® Acquires SeQure DxLSE:MXCTMaxcyte Inc
13/01/202511h43Alliance NewsAlliance NewsMaxCyte raises 2024 revenue guide again, ahead of final reportLSE:MXCTMaxcyte Inc
13/01/202509h05RNS Regulatory NewsMaxCyte, Inc. Preliminary Fourth Quarter and Full Year ResultsLSE:MXCTMaxcyte Inc
23/12/202408h00RNS Regulatory NewsMaxCyte, Inc. MaxCyte Announces Retirement of Board MemberLSE:MXCTMaxcyte Inc
09/12/202413h29Alliance NewsAlliance NewsMaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savingsLSE:MXCTMaxcyte Inc
09/12/202408h00RNS Regulatory NewsMaxCyte, Inc. MaxCyte Streamlines Operations and Raises GuidanceLSE:MXCTMaxcyte Inc
02/12/202418h09RNS Regulatory NewsMaxCyte, Inc. Total Voting Rights and Block Listing ReturnLSE:MXCTMaxcyte Inc
08/11/202415h41Alliance NewsAlliance NewsMaxCyte third-quarter profit falls amid surging costsLSE:MXCTMaxcyte Inc
07/11/202408h00RNS Regulatory NewsMaxCyte, Inc. Filing of 10Q formLSE:MXCTMaxcyte Inc
07/11/202408h00RNS Regulatory NewsMaxCyte, Inc. Third Quarter 2024 Financial ResultsLSE:MXCTMaxcyte Inc
06/11/202422h05UK RegulatoryMaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceLSE:MXCTMaxcyte Inc
31/10/202413h05RNS Non-RegulatoryMaxCyte, Inc. Upcoming Investor ConferencesLSE:MXCTMaxcyte Inc
18/10/202410h24RNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
15/10/202414h05RNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Cynthia Collins to BoardLSE:MXCTMaxcyte Inc
10/10/202414h05RNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCOLSE:MXCTMaxcyte Inc
16/09/202411h33Alliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
16/09/202408h00RNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
16/09/202408h00RNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
06/09/202412h33RNS Non-RegulatoryMaxCyte, Inc. Bioprocessing Conference ParticipationLSE:MXCTMaxcyte Inc
07/08/202415h10Alliance NewsAlliance NewsMaxCyte reaffirms guidance as revenue jumps 24% in first halfLSE:MXCTMaxcyte Inc
07/08/202408h05RNS Regulatory NewsMaxCyte, Inc. Filing of Form 10-QLSE:MXCTMaxcyte Inc
07/08/202408h00RNS Regulatory NewsMaxCyte, Inc. Second Quarter and Half-Year ResultsLSE:MXCTMaxcyte Inc
09/07/202410h14RNS Regulatory NewsMaxCyte, Inc. Change of Name of Nominated Adviser and BrokerLSE:MXCTMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCT

Dernières Valeurs Consultées

BITMOT
871779
Bund Green Bond Tf 0% Ag...
BITMOT
980749
Intsanpaolo Tf 4,5% Ap25...
BIT
I07276
INTESA SANPAOLO
BITMOT
890917
Kfw Green Bond Tf 5,8% G...
BITMOT
3080290
Bplmortgages Fr Eur1m+0....
LATK
CLVXUSDT
Calvex
NASDAQ
USCL
iShares Climate Consciou...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces